Wed Aug 5 18:25:39 SGT 2015  
SINGAPORE
VACCINE™
    Vaccine, Singapore (SG)

Vaccine, Singapore (SG)

Summary

Vaccine, Singapore (SG) @singaporevaccine_com: vaccine jab/shot/injection schedule, to vaccinate against the infection, to immunise against infectious disease, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Vaccine types available for vaccination / immunisation (uk) / immunization (us) :

Vaccine Against Disease Age D
o
s
e
s
Dose schedule Price
per
dose
(SG$)
Live attenuated
MMR vaccine ≥12m 1 $70/=
Measles virus Measles
Mumps virus Mumps
Rubella virus Rubella
Varilrix™ Varicella zoster virus
HHV-3
Varicella Chickenpox 12m-12y 1 $121/=
≥13y 2 6-10w interval
Zostavax™ Herpes zoster Shingles ≥50y 1 $295/=
Stamaril® Yellow fever virus Yellow fever 9m-59y 1 10 yearly $250/=
Inactivated / Whole / Viral & Bacterial
Rabipur® Rabies virus Rabies any 3 d 0, 7, & 21 or 28 $call/=
Ixiaro® Japanese encephalitis virus Japanese encephalitis ≥17y 2 2nd: 28d after 1st $386/=
1 Booster: 12-24m after 2nd
Dukoral® Vibrio cholerae Cholera 2-6y 3 1-6w interval $113/=
1 Booster: 6m after 3rd
≥6y 2 1-6w interval
1 Booster: 2y after 2nd
Inactivated / Fractional / Protein
Intanza™ Influenza virus Influenza 18-59y 1 1 yearly $30/=
Fluarix™ Influenza virus Influenza 6-36m ½ 1 yearly $30/=
>3y 1
Tetavax Clostridium tetani Tetanus adults 3 1-2m interval
3rd @ 6-12m
after 2nd
$30/=
booster 1 10 yearly
Boostrix® ≥4y 1 <10 yearly $70/=
Corynebacterium diphtheriae Diphtheria
Clostridium tetani Tetanus
Bordetella pertussis Pertussis
Whooping cough
Inactivated / Fractional / Polysaccharide / Pure
Typhim Vi® Salmonella typhi Typhoid fever >5y 1 3 yearly $48/=
Mencevax® ACWY Neisseria meningitidis
types A, C, W-135
and Y
Meningococcal meningitis >2y 1 $80/=
Inactivated / Fractional / Polysaccharide / Conjugate
Menactra® Neisseria meningitidis
types A, C, W-135
and Y
Meningococcal meningitis 2-55y 1 $195/=
Prevenar 13® (SG) /
Prevnar 13® (US)
Streptococcus pneumoniae
types 1, 3, 4, 5,
6A, 6B, 7F, 9V, 14,
18C, 19A, 19F, 23F
Pneumococcal infection 6w-6m 4 1m interval
4th @ 12-15m
$274/=
7-11m 2 1m interval
12-23m 2 2m interval
2-5y 1
≥50y 1

If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.

Testing for immunity against the following is available:

Virus Antibody Test Price
Varicella zoster virus Varicella Zoster IgG Antibody $44/=
Measles virus Measles IgG Antibody $90/=
Rubella virus Rubella IgG Antibody $24/=
Hepatitis A virus Hepatitis A IgG Antibody $30/=
Hepatitis B virus Hepatitis B surface Antibody $10/=

Other vaccines not stocked

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Vaccine, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

vaccine/ target=_blank rel="nofollow">That New Ebola Vaccine Is Related To The Rabies Virus. So Why Is It Safe?
Tue, 04 Aug 2015 18:00:00 +0100 | Forbes.com Healthcare News
All you need to know about rVSV-ZEBOV, the experimental vaccine against Ebola virus disease (Source: Forbes.com Healthcare News)

Vulvar Intraepithelial Neoplasia (VIN) and Condylomata
Tue, 04 Aug 2015 17:47:51 +0100 | Clinical Obstetrics and Gynecology
Human papillomavirus (HPV) infection of the lower genital tract is common and its effects are variable. The majority of infections are transient and the related pathology is self-resolving. Condyloma accuminatum is caused predominantly by HPV 6, 11 and can be managed with medical or surgical therapy. Vulvar intraepithelial neoplasia is a treatable precursor to vulvar cancer with 2 main forms: one related to HPV and the other to chronic vulvar inflammatory conditions. It may be treated medically, surgically, or potentially via the use of therapeutic HPV vaccines. Preventive utilization of a quadrivalent HPV vaccine has the potential to decrease HPV-related lower genital disease burden substantially. (Source: Clinical Obstetrics and Gynecology)

Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice
Tue, 04 Aug 2015 15:21:06 +0100 | BioMed Central
Conclusion:

Invasive pneumococcal disease in Australia, 2009 and 2010.
Tue, 04 Aug 2015 15:11:49 +0100 | Communicable Diseases Intelligence Quarterly Report
Authors: Bareja C, Toms C, Lodo K, de Kluyver R, Enhanced Invasive Pneumococcal Disease Surveillance Working Group

Australian National Enterovirus Reference Laboratory annual report, 2013.
Tue, 04 Aug 2015 15:11:49 +0100 | Communicable Diseases Intelligence Quarterly Report
Authors: Roberts JA, Hobday LK, Ibrahim A, Aitkin T, Thorley BR

Influenza outbreak preparedness: lessons from outbreaks in residential care facilities in 2014.
Tue, 04 Aug 2015 15:11:49 +0100 | Communicable Diseases Intelligence Quarterly Report
This report describes 6 influenza outbreaks in residential care facilities during the 2014 influenza season in the Sydney Local Health District. Vaccination rates were high among residents (95%) and low among staff (39%). The majority of residents with laboratory confirmed influenza (67%) did not meet the influenza-like illness case definition.Positive influenza specimens were subtyped as H3N2 (40%), H1N1 (5%) or not subtyped (55%). We illustrate the implications of low vaccine effectiveness and antigenic drift, and provide recommendations for the effective management of future influenza outbreaks.

Interim estimates of male human papillomavirus vaccination coverage in the school-based program in Australia.
Tue, 04 Aug 2015 15:11:49 +0100 | Communicable Diseases Intelligence Quarterly Report
Authors: Brotherton JM, Batchelor MR, Bradley MO, Brown SA, Duncombe SM, Meijer D, Tracey LE, Watson M, Webby RJ

Supplemental use of an interferon-gamma release assay in a state-wide tuberculosis contact tracing program in Victoria: a six-year review.
Tue, 04 Aug 2015 15:11:49 +0100 | Communicable Diseases Intelligence Quarterly Report
CONCLUSIONS: Our experience suggests that IGRA are able to be incorporated safely and effectively as a supplement to TST-based contact tracing.

vaccines/5089405.article?referrer=RSS target=_blank rel="nofollow">Best ways to allay parental concerns about vaccines
Tue, 04 Aug 2015 12:35:00 +0100 | Nursing Times Breaking News
Highlighting facts about the dangers of diseases can positively change sceptical parents’ attitudes to immunisation as opposed to approaches that focus on debunking vaccine myths, say US researchers. (Source: Nursing Times Breaking News)

Nigeria: Fighting Polio and the Burden of Tackling Fear
Tue, 04 Aug 2015 11:36:23 +0100 | AllAfrica News: Polio
[Daily Trust] It may no longer be news that many average persons in the regions where the polio virus is endemic, namely Northern Nigeria (even though there have not been any reported case in the country within the last one year), Pakistan and Afghanistan, often say the polio vaccine is aimed at depopulating Muslims. (Source: AllAfrica News: Polio)